Free Trial
NASDAQ:NVOS

Novo Integrated Sciences (NVOS) Stock Price, News & Analysis

$0.0020 0.00 (0.00%)
As of 10/15/2026

About Novo Integrated Sciences Stock (NASDAQ:NVOS)

Advanced

Key Stats

Today's Range
$0.0020
▼
$0.0020
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.06
Volume
48 shs
Average Volume
7,159 shs
Market Capitalization
$39.46 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) is a healthcare company focused on providing multidisciplinary medical services and developing or commercializing healthcare-related products and technologies. Its business model is centered on integrated, patient-focused care delivered through affiliated and subsidiary operations.

Through its Canadian healthcare operations, including Novo Healthnet Limited, the company has provided services such as primary care, physiotherapy, chiropractic care, massage therapy, acupuncture, occupational therapy and other allied-health treatments. Its healthcare services are designed to support preventative care, rehabilitation, chronic-condition management and general wellness.

Novo Integrated Sciences has also pursued opportunities involving medical technology, telehealth and healthcare products intended to complement its clinical-services platform. The company’s operating history has primarily been associated with Canada, particularly Ontario, while it has explored broader geographic and commercial expansion. Robert Mattacchione has been identified in company filings and announcements as the company’s chairman and chief executive officer.

AI Generated. May Contain Errors.

Receive NVOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVOS Stock News Headlines

INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and built in a matter of weeks. James Altucher says the site could go live as soon as October 21 and has put together a free presentation explaining what is happening inside and why the timing matters.tc pixel
See More Headlines

NVOS Stock Analysis - Frequently Asked Questions

Novo Integrated Sciences' stock was trading at $0.0027 at the start of the year. Since then, NVOS shares have decreased by 25.9% and is now trading at $0.0020.

Shares of Novo Integrated Sciences reverse split on Tuesday, November 7th 2023.The 1-10 reverse split was announced on Tuesday, November 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of NVOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novo Integrated Sciences investors own include Tesla (TSLA), T2 Biosystems (TTOO), Workhorse Group (WKHS), Avalo Therapeutics (AVTX), Canopy Growth (CGC), Cybin (HELP) and SeaStar Medical (ICU).

Company Calendar

Today
10/16/2026
Fiscal Year End
8/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
NASDAQ:NVOS
CIK
1138978
Fax
N/A
Employees
115
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
($0.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.17 million
Net Margins
-121.55%
Pretax Margin
-121.32%
Return on Equity
-93.07%
Return on Assets
-46.28%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
0.37
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$13.52 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.77 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
19,730,000
Free Float
17,678,000
Market Cap
$39.46 thousand
Optionable
Not Optionable
Beta
5.83

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:NVOS) was last updated on 10/15/2026 by MarketBeat.com Staff.
From Our Partners